Patents

Galderma Patents Oral Acne Treatment

US Patent No. 8,658,189 B2; Galderma has been awarded a patent for an oral method of treating acne in a human. It entails administering systemically a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound. 

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters